RhumbLine Advisers’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$94.6K	Buy	7,714 +479	+7%	+$5.88K	﹤0.01%	3548
2025 Q1	$79.7K	Buy	+7,235	New	+$79.7K	﹤0.01%	3461